Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Research article

Role of gait speed and grip strength in predicting 10-year cognitive decline among community-dwelling older people

Authors: Ming-Yueh Chou, Yukiko Nishita, Takeshi Nakagawa, Chikako Tange, Makiko Tomida, Hiroshi Shimokata, Rei Otsuka, Liang-Kung Chen, Hidenori Arai

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

The gait speed and handgrip strength represented the core determinants of physical frailty and sarcopenia, which were reported to be associated with cognitive impairment and decline. Different physical measures might differentially affect cognitive changes, such as higher-level cognitive change and global cognitive decline. This study examined the differential associations of gait speed and handgrip strength with 10-year cognitive changes among community-dwelling older people.

Methods

Participants aged 60 years and over living in the community were invited for study. Gait speed and handgrip strength were classified into 5 groups based on quintiles at baseline. Cognitive functions were assessed using the Mini-Mental State Examination (MMSE) and Digit Symbol Substitution Test (DSST) every 2 years from baseline for a period of 10 years. Linear mixed effects models were used to determine the role of gait speed and handgrip strength in the prediction of 10-year cognitive changes by adjusting covariates, including age, gender, education, depressive symptoms, marital status, smoking status, instrumental activities of daily life (IADL), Charlson Comorbidity Index (CCI), and body mass index (BMI) at baseline.

Results

A total of 1096 participants were enrolled in the study. The mean age was 69.4 ± 5.8 years and 50.9% were male. The slowest gait speed group showed a significantly greater decline in the DSST scores over 10 years than the highest group (estimate = 0.28 and P = 0.003), but not in the MMSE scores (estimate = 0.05 and P = 0.078). The lowest handgrip strength group showed a significantly greater decline in the MMSE scores than the highest group (estimate = 0.06 and P = 0.039) and in the DSST scores than the highest two quintiles (estimate = 0.20 and P = 0.033 for the fourth quintile; estimate = 0.20 and P = 0.040 for the highest quintile) over 10-year follow-up.

Conclusions

A slow gait speed could predict 10-year cognitive decline using DSST, and a low handgrip strength could predict 10-year cognitive decline using MMSE in addition to DSST. Thus both physical measures are lined to cognitive decline but there may be different mechanisms between brain and physical functions.
Appendix
Available only for authorised users
Literature
1.
Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. World Alzheimer Report 2015. In: The global impact of dementia. Alzheimer’s disease international. London: Alzheimer’s Disease International (ADI). p. 2015.
2.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75 e62.PubMedCrossRef
3.
Li C, Dowling NM, Chappell R. Quantile regression with a change-point model for longitudinal data: an application to the study of cognitive changes in preclinical alzheimer's disease. Biometrics. 2015;71(3):625–35.PubMedPubMedCentralCrossRef
4.
Howieson DB. Cognitive decline in Presymptomatic Alzheimer disease. JAMA Neurol. 2016;73(4):384–5.PubMedCrossRef
5.
Brasure M, Desai P, Davila H, Nelson VA, Calvert C, Jutkowitz E, Butler M, Fink HA, Ratner E, Hemmy LS, et al. Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018;168(1):30–8.PubMedCrossRef
6.
de la Torre JC. Alzheimer's disease is incurable but preventable. J Alzheimers Dis. 2010;20(3):861–70.PubMedCrossRef
7.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.PubMedCrossRef
8.
Wolinsky FD, Bentler SE, Hockenberry J, Jones MP, Weigel PA, Kaskie B, Wallace RB. A prospective cohort study of long-term cognitive changes in older Medicare beneficiaries. BMC Public Health. 2011;11(1):710.PubMedPubMedCentralCrossRef
9.
Martin KL, Blizzard L, Wood AG, Srikanth V, Thomson R, Sanders LM, Callisaya ML. Cognitive function, gait, and gait variability in older people: a population-based study. J Gerontol A Biol Sci Med Sci. 2013;68(6):726–32.PubMedCrossRef
10.
Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78(9):929–35.PubMedPubMedCentralCrossRef
11.
Inzitari M, Newman AB, Yaffe K, Boudreau R, de Rekeneire N, Shorr R, Harris TB, Rosano C. Gait speed predicts decline in attention and psychomotor speed in older adults: the health aging and body composition study. Neuroepidemiology. 2007;29(3–4):156–62.PubMedPubMedCentralCrossRef
12.
Hsu CL, Liang CK, Liao MC, Chou MY, Lin YT. Slow gait speed as a predictor of 1-year cognitive decline in a veterans' retirement community in southern Taiwan. Geriatr Gerontol Int. 2017;17:14–9.PubMedCrossRef
13.
Sternäng O, Reynolds CA, Finkel D, Ernsth-Bravell M, Pedersen NL, Dahl Aslan AK. Grip strength and cognitive abilities: associations in old age. J Gerontol B Psychol Sci Soc Sci. 2015;71(5):841–8.PubMedPubMedCentralCrossRef
14.
Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17(12):1164 e1167–15.CrossRef
15.
Buracchio T, Dodge HH, Howieson D, Wasserman D, Kaye J. The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol. 2010;67(8):980–6.PubMedPubMedCentralCrossRef
16.
Demnitz N, Esser P, Dawes H, Valkanova V, Johansen-Berg H, Ebmeier KP, Sexton C. A systematic review and meta-analysis of cross-sectional studies examining the relationship between mobility and cognition in healthy older adults. Gait Posture. 2016;50:164–74.PubMedPubMedCentralCrossRef
17.
18.
Proust-Lima C, Amieva H, Dartigues J-F, Jacqmin-Gadda H. Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population–based studies. Am J Epidemiol. 2006;165(3):344–50.PubMedCrossRef
19.
Iwasa H, Kai I, Yoshida Y, Suzuki T, Kim H, Yoshida H. Information processing speed and 8-year mortality among community-dwelling elderly Japanese. J Epidemiol. 2014;24(1):52–9.PubMedCrossRef
20.
Rapp MA, Reischies FM. Attention and executive control predict Alzheimer disease in late life: results from the Berlin aging study (BASE). Am J Geriatr Psychiatry. 2005;13(2):134–41.PubMedCrossRef
21.
Iwasa H, Gondo Y, Yoshida Y, Kwon J, Inagaki H, Kawaai C, Masui Y, Kim H, Yoshida H, Suzuki T. Cognitive performance as a predictor of functional decline among the non-disabled elderly dwelling in a Japanese community: a 4-year population-based prospective cohort study. Arch Gerontol Geriatr. 2008;47(1):139–49.PubMedCrossRef
22.
Edwards JD, Wadley VG, Vance DE, Wood K, Roenker DL, Ball KK. The impact of speed of processing training on cognitive and everyday performance. Aging Ment Health. 2005;9(3):262–71.PubMedCrossRef
23.
Clouston SA, Brewster P, Kuh D, Richards M, Cooper R, Hardy R, Rubin MS, Hofer SM. The dynamic relationship between physical function and cognition in longitudinal aging cohorts. Epidemiol Rev. 2013;35:33–50.PubMedPubMedCentralCrossRef
24.
Shimokata H, Ando F, Niino N. A new comprehensive study on aging--the National Institute for longevity sciences, longitudinal study of aging (NILS-LSA). J Epidemiol. 2000;10(1 Suppl):S1–9.PubMedCrossRef
25.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM, Cruz-Gentoft AJ, et al. Sarcopenia: European consensus on definition and diagnosis Report of the European working group on sarcopenia in older People. Age Ageing. 2010;39(4):412–23.PubMedPubMedCentralCrossRef
26.
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, et al. Sarcopenia in Asia: consensus report of the Asian working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.PubMedCrossRef
27.
Nakamoto M, Otsuka R, Yuki A, Nishita Y, Tange C, Tomida M, Kato Y, Ando F, Shimokata H, Suzuki T. Higher gait speed and smaller sway area decrease the risk for decline in higher-level functional capacity among middle-aged and elderly women. Arch Gerontol Geriatr. 2015;61(3):429–36.PubMedCrossRef
28.
Kozakai R, Ando F, Kim HY, Yuki A, Otsuka R, Shimokata H. Sex-differences in age-related grip strength decline: a 10-year longitudinal study of community-living middle-aged and older Japanese. Jpn J Phys Fitness Sports Med. 2016;5(1):87–94.CrossRef
29.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.PubMedCrossRef
30.
Mori E. Usefulness of a Japanese version of the mini-mental state test in neurological patients. Jpn J Neuropsychol. 1985;1:82–90.
31.
Misawa G, Kobayashi S, Fujita K, Maekawa H, Dairoku H. Japanese wechsler adult intelligence scale-revised short forms. Tokyo: Nihon Bunka Kagakusha; 1993.
32.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef
33.
Koyano W, Shibata H, Nakazato K, Haga H, Suyama Y. Measurement of competence: reliability and validity of the TMIG index of competence. Arch Gerontol Geriatr. 1991;13(2):103–16.PubMedCrossRef
34.
Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med care. 2005;43(6):607-15.PubMedCrossRef
35.
36.
Morrell CH, Brant LJ, Ferrucci L. Model choice can obscure results in longitudinal studies. J Gerontol A Biol Sci Med Sci. 2009;64(2):215–22.PubMedCrossRef
37.
Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The physical activity guidelines for Americans. Jama. 2018;320(19):2020–8.PubMedCrossRef
38.
Singh-Manoux A, Richards M, Marmot M. Leisure activities and cognitive function in middle age: evidence from the Whitehall II study. J Epidemiol Community Health. 2003;57(11):907–13.PubMedPubMedCentralCrossRef
39.
McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119(1–3):1–8.PubMedCrossRef
40.
Hsu YH, Liang CK, Chou MY, Liao MC, Lin YT, Chen LK, Lo YK. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern T aiwan: a cross-sectional study. Geriatr Gerontol Int. 2014;14:102–8.PubMedCrossRef
41.
Gao Y, Huang C, Zhao K, Ma L, Qiu X, Zhang L, Xiu Y, Chen L, Lu W, Huang C. Retracted: depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int J Geriatr Psychiatry. 2013;28(5):441–9.PubMedCrossRef
42.
Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002;59(3):371–8.PubMedCrossRef
43.
Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, Guralnik JM, Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59(3):242–8.PubMedCrossRef
44.
Hogervorst E, Bandelow S, Combrinck M, Smith A. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11–12):1633–9.PubMedCrossRef
45.
Best JR, Liu-Ambrose T, Boudreau RM, Ayonayon HN, Satterfield S, Simonsick EM, Studenski S, Yaffe K, Newman AB, Rosano C. An evaluation of the longitudinal, bidirectional associations between gait speed and cognition in older women and men. J Gerontol A Biol Sci Med Sci. 2016;71(12):1616–23.PubMedPubMedCentralCrossRef
46.
Gale CR, Allerhand M, Sayer AA, Cooper C, Deary IJ. The dynamic relationship between cognitive function and walking speed: the English longitudinal study of ageing. Age. 2014;36(4):9682.PubMedPubMedCentralCrossRef
47.
Smith EE, O’Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, Poirier P, Stotts G, Black SE, Strother S, et al. Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol. 2015;77(2):251–61.PubMedPubMedCentralCrossRef
48.
Holtzer R, Epstein N, Mahoney JR, Izzetoglu M, Blumen HM. Neuroimaging of mobility in aging: a targeted review. J Gerontol A Biol Sci Med Sci. 2014;69(11):1375–88.PubMedPubMedCentralCrossRef
49.
Baillieux H, De Smet HJ, Paquier PF, De Deyn PP, Mariën P. Cerebellar neurocognition: insights into the bottom of the brain. Clin Neurol Neurosurg. 2008;110(8):763–73.PubMedCrossRef
50.
Belghali M, Chastan N, Cignetti F, Davenne D, Decker LM. Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer’s and Parkinson’s diseases. GeroScience. 2017;39(3):305–29.PubMedPubMedCentralCrossRef
51.
Alfaro-Acha A, Al Snih S, Raji MA, Kuo YF, Markides KS, Ottenbacher KJ. Handgrip strength and cognitive decline in older Mexican Americans. J Gerontol A Biol Sci Med Sci. 2006;61(8):859–65.PubMedCrossRef
52.
Auyeung TW, Lee J, Kwok T, Woo J. Physical frailty predicts future cognitive decline—a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging. 2011;15(8):690–4.PubMedCrossRef
53.
Taekema DG, Gussekloo J, Maier AB, Westendorp RG, de Craen AJ. Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old. Age Ageing. 2010;39(3):331–7.PubMedCrossRef
54.
Ward NS, Newton JM, Swayne OB, Lee L, Frackowiak RS, Thompson AJ, Greenwood RJ, Rothwell JC. The relationship between brain activity and peak grip force is modulated by corticospinal system integrity after subcortical stroke. Eur J Neurosci. 2007;25(6):1865–73.PubMedPubMedCentralCrossRef
55.
Ismail S, Mohamad M, Syazarina S, Nafisah W. Hand grips strength effect on motor function in human brain using fMRI: a pilot study. In: Journal of Physics: Conference Series; 2014. p. 012005.
56.
Olivier E, Davare M, Andres M, Fadiga L. Precision grasping in humans: from motor control to cognition. Curr Opin Neurobiol. 2007;17(6):644–8.PubMedCrossRef
57.
Callisaya ML, Beare R, Phan TG, Blizzard L, Thrift AG, Chen J, Srikanth VK. Brain structural change and gait decline: a longitudinal population-based study. J Am Geriatr Soc. 2013;61(7):1074–9.PubMedCrossRef
58.
Heuninckx S, Wenderoth N, Debaere F, Peeters R, Swinnen SP. Neural basis of aging: the penetration of cognition into action control. J Neurosci. 2005;25(29):6787–96.PubMedPubMedCentralCrossRef
Metadata
Title
Role of gait speed and grip strength in predicting 10-year cognitive decline among community-dwelling older people
Authors
Ming-Yueh Chou
Yukiko Nishita
Takeshi Nakagawa
Chikako Tange
Makiko Tomida
Hiroshi Shimokata
Rei Otsuka
Liang-Kung Chen
Hidenori Arai
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1199-7

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue

Research article

Prevalence of Potentially Inappropriate Medication use in older drivers

Study protocol

Effectiveness of a tele-rehabilitation intervention to improve performance and reduce morbidity for people post hip fracture - study protocol for a randomized controlled trial

Research article

Quality of prescribing predicts hospitalisation in octogenarians: life and living in advanced age: a cohort study in New Zealand (LiLACS NZ)

Research article

Dose-response association between physical activity and sedentary time categories on ageing biomarkers

Research article

Improved outcome in hip fracture patients in the aging population following co-managed care compared to conventional surgical treatment: a retrospective, dual-center cohort study

Study protocol

Older people living alone (OPLA) – non-kin-carers’ support towards the end of life: qualitative longitudinal study protocol
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits